These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34505827)

  • 41. Increasing hepatitis B vaccination coverage of healthcare workers - global lessons for South Africa.
    Burnett RJ; Dramowski A; Amponsah-Dacosta E; Meyer JC
    Curr Opin Immunol; 2021 Aug; 71():6-12. PubMed ID: 33819774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
    Lu PJ; Byrd KK; Murphy TV; Weinbaum C
    Vaccine; 2011 Sep; 29(40):7049-57. PubMed ID: 21782873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.
    Schillie S; Vellozzi C; Reingold A; Harris A; Haber P; Ward JW; Nelson NP
    MMWR Recomm Rep; 2018 Jan; 67(1):1-31. PubMed ID: 29939980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knowledge, attitudes and practices of undergraduate health sciences students on hepatitis B vaccination at a South African university highlight the need for improvement of policies, implementation and co-ordination.
    Makan N; Song E; Kramvis A
    S Afr Med J; 2023 May; 113(5):39-45. PubMed ID: 37170608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
    Harris A; Yong K; Kermode M
    Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low Level of Hepatitis B Virus Infection in Children 20 Years After Initiation of Infant Vaccination Program in Wallis and Futuna.
    Pezzoli L; Mathelin JP; Hennessey K; Eswara-Aratchige P; Valiakolleri J; Kim SH
    Am J Trop Med Hyg; 2017 Mar; 96(3):715-719. PubMed ID: 28070010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers.
    Schillie S; Murphy TV; Fenlon N; Ko S; Ward JW
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1118-20. PubMed ID: 26447601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Groom HC; Irving SA; Koppolu P; Smith N; Vazquez-Benitez G; Kharbanda EO; Daley MF; Donahue JG; Getahun D; Jackson LA; Tse Kawai A; Klein NP; McCarthy NL; Nordin JD; Sukumaran L; Naleway AL
    Vaccine; 2018 Oct; 36(41):6111-6116. PubMed ID: 30194002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination.
    Tarhan MO; Aker AI; Sipahi OR; Kardes G; Biberoglu K
    Med Sci Monit; 2006 Nov; 12(11):CR467-70. PubMed ID: 17072271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine.
    Leroux-Roels G; Haelterman E; Maes C; Levy J; De Boever F; Licini L; David MP; Dobbelaere K; Descamps D
    Clin Vaccine Immunol; 2011 Sep; 18(9):1510-8. PubMed ID: 21734063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination with HepB-CpG vaccine in individuals undergoing immune suppressive drug therapy.
    Perrillo R; Garrido LF; Ma TW; Rahimi R; Lilly B
    Vaccine; 2023 Jul; 41(31):4457-4461. PubMed ID: 37353450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Amjad W; Alukal J; Zhang T; Maheshwari A; Thuluvath PJ
    Dig Dis Sci; 2021 Jun; 66(6):2101-2106. PubMed ID: 32617767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
    Halperin SA; Ward B; Cooper C; Predy G; Diaz-Mitoma F; Dionne M; Embree J; McGeer A; Zickler P; Moltz KH; Martz R; Meyer I; McNeil S; Langley JM; Martins E; Heyward WL; Martin JT
    Vaccine; 2012 Mar; 30(15):2556-63. PubMed ID: 22326642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge of Healthcare Professionals on Hepatitis B Virus Infection and Vaccination Uptake in a Tertiary Hospital in Nigeria.
    Suleiman ST; Ogunfemi MK; Bojuwoye MO; Omokanye KO; Bello AH; Idris SO; Ahmed A; Oni JO; Imran J; Oyewopo CI
    West Afr J Med; 2023 Aug; 40(8):808-813. PubMed ID: 37639332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
    Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
    Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.